QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Government mandates science-based PFAS health guidance for exposed communities

H.R. 6977 — Better Care for PFAS Patients Act of 2026 · Filed by Maxine Dexter (D-OR) · 1 cosponsor · Introduced Jan 8, 2026 · Referred to committee

85%
Transparency
Typical bill: 85%
5/100
Hidden-provision risk
Typical bill: 15/100
Public Health Assessment Mandate

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill requires the federal government to contract with the National Academies of Sciences to assess the health effects of PFAS (forever chemicals) found in human tissues, develop clinical recommendations for treating PFAS-exposed patients, and issue public guidance for doctors and health authorities. The initial assessment must be completed within 2 years, updated every 5 years or more often if science warrants, and must include input from communities exposed to PFAS.

Why we flagged it

The bill's core function is to establish a recurring, science-based assessment and guidance process for PFAS health effects. It is a procedural and informational mandate, not a regulatory or appropriations measure.

What the text implies

  • By mandating community consultation, the bill creates a formal channel for PFAS-exposed populations to influence federal health guidance, potentially strengthening their voice in future regulatory or remediation decisions.
  • The 5-year update cycle with discretionary acceleration creates a mechanism for the government to respond quickly if new PFAS science emerges, avoiding the lag that often occurs between discovery and clinical guidance.
  • Public posting of guidance on ATSDR's website and dissemination to state/local authorities may accelerate adoption of consistent PFAS screening and treatment protocols across fragmented U.S. health systems.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates a structured, science-based process to understand and address PFAS health harms, ensuring affected communities have a voice and that doctors receive evidence-based guidance. It imposes no restrictions on citizens' rights or remedies and mandates transparency through public posting of findings.

Named in the bill

Agency for Toxic Substances and Disease Registry (ATSDR), National Academies of Sciences, Engineering, and Medicine, PFAS-exposed communities, State and local public health authorities

Where it stands

1 cosponsor: 1 Republicans.

  • Jan 8, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Jan 8, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $2,140,000 in lobbying spend. A filing names 147 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Maxine Dexter, the sponsor, reported $365,744 in PAC receipts in the 2026 cycle.

  • American Property Casualty Insurance Association — $2,140,000 on 1 filing

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (2,532 characters) on Jul 25, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Jul 22, 2026 · page rendered 2026-10-20.

“Government mandates science-based PFAS health guidance for exposed communities” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6977 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.